drugset / Trial / NCT02559505

Influenza Immunity in Children

NCT02559505

Completed 134 enrolled University of Rochester
Non-randomizedParallel-groupOpen-labelBasic science

Summary

This study evaluates how different methods of early exposure to influenza (natural infection, live attenuated influenza vaccination, inactivated influenza vaccination) initially stimulate immunity and poise the immune system to respond to a future challenge with the inactivated influenza vaccine.

Timeline

Start
2015-10
Primary completion
2020-07-03
Completion
2020-07-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine 0.25 ml Intramuscular
Subject Influenza Virus Vaccine Vaccine 0.5 ml Intramuscular

Indications